Skip to content
Hair Pipeline
← Back to the pipeline

TH07

An undisclosed Triple Hair topical at phase 3.

Phase 3TopicalUndisclosed
Developed by
Triple Hair
Current phase
Phase 3

Large confirmatory trials. The last step before filing.

Indications
Androgenetic alopecia
Last public activity
March 2026
Record confidence
Low

Why it matters

A small Canadian developer running a phase 3 without any of the funding coverage the American programmes attract. Recorded so that the trial is findable; the composition is not disclosed.

Development history

  1. Phase 3

    First Phase 3 trial on record: NCT07435012 — Androgenic Alopecia TH07 Clinical Trial

    ClinicalTrials.gov ↗

Registered trials

Pulled automatically from ClinicalTrials.gov. Matching is by name and development code, so occasional gaps are possible — tell us if you spot one.

  • NCT07435012Phase 3RECRUITING

    Androgenic Alopecia TH07 Clinical Trial

    Triple Hair Inc · n=420 · April 2026

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first.

Sources